Your browser doesn't support javascript.
loading
Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression.
Obermannová, R; Van Cutsem, E; Yoshino, T; Bodoky, G; Prausová, J; Garcia-Carbonero, R; Ciuleanu, T; Garcia Alfonso, P; Portnoy, D; Cohn, A; Yamazaki, K; Clingan, P; Lonardi, S; Kim, T W; Yang, L; Nasroulah, F; Tabernero, J.
Afiliación
  • Obermannová R; Masaryk Memorial Cancer Institute, Brno, Czech Republic obermannova@mou.cz.
  • Van Cutsem E; University Hospitals Leuven and KU Leuven, Leuven, Belgium.
  • Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Bodoky G; Department of Oncology, St László Hospital, Budapest, Hungary.
  • Prausová J; Onocology Clinic, Charles University, Prague, Czech Republic.
  • Garcia-Carbonero R; Department of Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain.
  • Ciuleanu T; Institutul Oncologic Ion Chiricuta and UMF, Cluj-Napoca, Romania.
  • Garcia Alfonso P; Department of Oncology, Hospital General Universitario Gregorio Maranón, Madrid, Spain.
  • Portnoy D; The West Clinic-University of Tennessee Health Sciences Center, Memphis.
  • Cohn A; Rocky Mountain Cancer Center, Denver, USA.
  • Yamazaki K; Department of Gastrointestinal Oncology, Shizouka Cancer Center, Shizouka, Japan.
  • Clingan P; Southern Medical Day Care Centre, Wollongong, NSW, Australia.
  • Lonardi S; Department of Medical Oncology, Istituto Oncologico Veneto-IRCCS, Padova, Italy.
  • Kim TW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Yang L; Eli Lilly and Company, Bridgewater, USA.
  • Nasroulah F; Eli Lilly and Company, Buenos Aires, Argentine Republic.
  • Tabernero J; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.
Ann Oncol ; 27(11): 2082-2090, 2016 11.
Article en En | MEDLINE | ID: mdl-27573561
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Camptotecina / Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas p21(ras) / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: República Checa
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Camptotecina / Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas p21(ras) / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: República Checa